Alicia Parks
Psychiatric/Mental Health · Tampa, FLNPI 1770868796
Payments from drug & device makers
Across 410 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Johnson & Johnson$1K
- AbbVie$1K
- Neurocrine Biosciences, Inc.$950
- Alkermes, Inc.$940
- Otsuka America Pharmaceutical, Inc.$741
- plus $2K from 10 others
What the payments were for
- Food & beverage$8,24596%
- Education$3524%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 98 | $1,765 |
| Johnson & Johnson | 34 | $1,066 |
| AbbVie | 52 | $1,010 |
| Neurocrine Biosciences, Inc. | 52 | $950 |
| Alkermes, Inc. | 42 | $940 |
| Otsuka America Pharmaceutical, Inc. | 38 | $741 |
| E.r. Squibb & Sons, L.L.C. | 18 | $564 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $467 |
| Indivior Inc. | 19 | $344 |
| Sunovion Pharmaceuticals Inc. | 20 | $317 |
| Vanda Pharmaceuticals Inc. | 8 | $236 |
| Lundbeck LLC | 7 | $119 |
| Pfizer | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$471
- Austedo XR$464
- INVEGA SUSTENNA$418
- INVEGA TRINZA$271
- COBENFY$251
- ABILIFY ASIMTUFII$147
- ABILIFY MAINTENA$147
- CAPLYTA$143
- UZEDY$121
- INGREZZA$120
- Fanapt$119
- VRAYLAR$103
How this compares
$8,597 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 177 | $528,289 |
| Invega TrinzaPaliperidone Palmitate | 29 | $233,342 |
| Abilify MaintenaAripiprazole | 42 | $118,436 |
| Austedo XrDeutetrabenazine | 15 | $97,377 |
| Abilify AsimtufiiAripiprazole | 13 | $76,395 |
| VraylarCariprazine Hcl | 51 | $74,408 |
| PerserisRisperidone | 19 | $47,254 |
| CaplytaLumateperone Tosylate | 13 | $23,672 |
| RexultiBrexpiprazole | 16 | $22,510 |
| TrintellixVortioxetine Hydrobromide | 25 | $16,666 |
| Lurasidone Hcl | 62 | $16,207 |
| Aripiprazole | 167 | $8,030 |
| Quetiapine Fumarate | 374 | $4,665 |
| Risperidone | 267 | $4,522 |
| Olanzapine | 105 | $4,135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $1,066 | $761,631206 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Abilify Asimtufii, Rexulti | $741 | $217,34171 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,765 | $97,37715 claims |
| AbbVieVraylar | $1,010 | $74,40851 claims |
| Indivior Inc.Perseris | $344 | $47,25419 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $467 | $23,67213 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $14 | $16,66625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Tampa
- Cheedy JajaTampa$266K
- Tonya King-CharltonTampa$31K
- Michele CreamerTampa$18K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.